secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001193125-25-063253
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Whitehawk completes sale of Aadi Subsidiary to Kaken for $102.4M cash
---------------------------------------------------------------------

- Sale of 100% of Aadi Subsidiary, Inc. to KAKEN INVESTMENTS INC. closed on March 25, 2025.
- Cash purchase price of $102.4 million after adjustments paid by Purchaser.
- Pro forma financial information to be filed by amendment within four business days.
- Deal previously announced on December 19, 2024 under Stock Purchase Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/0001193125-25-063253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312525063253/d937606d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-063253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer